Peter Pitts
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Peter Pitts
Peter Pitts is recorded as Chairman and Board Member at Brainstorm Cell Therapeutics Inc. (BCLI). Brainstorm Cell Therapeutics Inc. reported in an 8-K filed May 28, 2026 that Peter Pitts was appointed director, effective May 25, 2026.
“On May 25, 2026, the Board of Directors (the “Board”) of Brainstorm Cell Therapeutics Inc. (the “Company”) approved an increase in the number of directors constituting the Board from seven to eight directors and appointed Peter Pitts to serve as a director of the Company, effective as of the same day, to serve until the Company’s 2026 Annual Meeting of Stockholders and until his successor is duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-07-24–present
-
Current
2026-07-24–present
-
Current
2026-05-25–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Brainstorm Cell Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Mr. Chaim Lebovits CEO
- Jacob A. Frenkel Chairman, Board Member
- Peter J. Pitts Chairman, Board Member
- Ms. Alla Patlis CFO
- Dr. Hartoun Hartounian COO
- Dr. Anthony Polverino Board Member
- Dr. Irit Arbel Board Member
- Dr. Jacob Frenkel Board Member
- Dr. Menghisteab Bairu Board Member
- Dr. Stacy Lindborg Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.